Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Clarentis

Clarentis?uq=8lCq2teR
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
Description

Manufacturer of non-toxic disinfectant and anti-microbial products designed to generate consistently high-quality, pure HOCl from to produce the biocidal disinfectant. The company's disinfectant and anti-microbial products kill common bacteria across a broad spectrum of applications and also eradicate antibiotic resistant strains of the most virulent pathogens found around the globe, enabling customers to reduce the amount of chemicals that they use to purify.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Other Industries
Biotechnology
Primary Office
  • 4440 PGA Boulevard
  • Suite 600
  • Palm Beach Gardens, FL 33410
  • United States

+1 (561) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Clarentis’s full profile, request a free trial.

Clarentis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Sep-2014 $10M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Clarentis Executive Team (2)

Name Title Board
Seat
Contact
Info
Duke Kalken Co-Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »